# Ganglioglioma anaplásico

> Página oficial: https://raras.org/doenca/ganglioglioma-anaplasico
> Fonte: Raras.org — Banco de Dados de Doenças Raras em Português (CC BY-NC-SA 4.0)
> Última atualização: 2026-05-07

## Identificadores

- **ORPHA**: 251957 — https://www.orpha.net/en/disease/detail/251957
- **CID-10**: D43.0

## Descrição clínica

A WHO grade III neuroepithelial neoplasm composed of neoplastic, mature ganglion cells and anaplastic glial cells. The anaplastic changes in the glial component and high MIB-1 and TP53 labeling indices may indicate aggressive behavior. However, the correlation of histological anaplasia with clinical outcome is inconsistent. (Adapted from WHO)

## Epidemiologia e herança


## Ensaios clínicos ativos (2)

- **NCT03919071** [ACTIVE_NOT_RECRUITING]: Dabrafenib Combined With Trametinib After Radiation Therapy in Treating Patients With Newly-Diagnosed High-Grade Glioma — https://clinicaltrials.gov/study/NCT03919071
- **NCT03975829** [ACTIVE_NOT_RECRUITING]: Pediatric Long-Term Follow-up and Rollover Study — https://clinicaltrials.gov/study/NCT03975829
- **NCT03434262** [COMPLETED]: SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors — https://clinicaltrials.gov/study/NCT03434262
- **NCT02684058** [COMPLETED]: Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors — https://clinicaltrials.gov/study/NCT02684058

## Importante

O Raras **não diagnostica e não prescreve**. Esta página é educativa e informativa.
Pacientes devem consultar profissionais de saúde qualificados para decisões clínicas.

---

**Citação sugerida**: Raras.org — Ganglioglioma anaplásico. Disponível em: https://raras.org/doenca/ganglioglioma-anaplasico
**Formato HTML**: https://raras.org/doenca/ganglioglioma-anaplasico
**Formato RDF/Turtle**: https://raras.org/api/rdf?orpha=251957